ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra

February 27, 1976

Environmental Carcinogenesis Gets 17% Of NCI Budget

February 20, 1976

Another Flat Budget For NIH And NCI Despite Strong Bipartisan Support.

January 11, 2008

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

Alternative to Animal Use In Research Outlined By OTA

February 21, 1986